Sokołowski, M.; Łacina, P.; Bogunia-Kubik, K.; Mazur, G.; Butrym, A.
Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes. Int. J. Mol. Sci. 2025, 26, 5237.
https://doi.org/10.3390/ijms26115237
AMA Style
Sokołowski M, Łacina P, Bogunia-Kubik K, Mazur G, Butrym A.
Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes. International Journal of Molecular Sciences. 2025; 26(11):5237.
https://doi.org/10.3390/ijms26115237
Chicago/Turabian Style
Sokołowski, Marcin, Piotr Łacina, Katarzyna Bogunia-Kubik, Grzegorz Mazur, and Aleksandra Butrym.
2025. "Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes" International Journal of Molecular Sciences 26, no. 11: 5237.
https://doi.org/10.3390/ijms26115237
APA Style
Sokołowski, M., Łacina, P., Bogunia-Kubik, K., Mazur, G., & Butrym, A.
(2025). Polymorphisms in Necroptosis Pathway Genes: Novel Prognostic Markers for Multiple Myeloma Treatment Outcomes. International Journal of Molecular Sciences, 26(11), 5237.
https://doi.org/10.3390/ijms26115237